PMV Pharmaceuticals, Inc. (PMVP)
NASDAQ: PMVP · Real-Time Price · USD
0.8522
-0.0118 (-1.37%)
May 13, 2025, 4:00 PM - Market closed
PMV Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 51.34 | 40.88 | 37.71 | 108.3 | 172.47 | 361.42 | Upgrade
|
| Short-Term Investments | 109.05 | 128.58 | 165.35 | 132.76 | 124.7 | - | Upgrade
|
| Cash & Short-Term Investments | 160.39 | 169.45 | 203.06 | 241.05 | 297.16 | 361.42 | Upgrade
|
| Cash Growth | -18.97% | -16.55% | -15.76% | -18.88% | -17.78% | 256.13% | Upgrade
|
| Prepaid Expenses | 3.11 | 6.2 | 3.53 | 5.13 | 3.3 | 3.34 | Upgrade
|
| Restricted Cash | - | - | 0.82 | 0.82 | 0.82 | - | Upgrade
|
| Total Current Assets | 163.5 | 175.66 | 207.41 | 247.01 | 301.29 | 364.76 | Upgrade
|
| Property, Plant & Equipment | 1.44 | 1.55 | 19.05 | 20.49 | 13.15 | 0.57 | Upgrade
|
| Long-Term Investments | 5.44 | 13.84 | 25.51 | 2.5 | 16.91 | - | Upgrade
|
| Other Long-Term Assets | 0.24 | 0.24 | 0.19 | 0.31 | 0.22 | 0.2 | Upgrade
|
| Total Assets | 170.61 | 191.29 | 252.15 | 270.31 | 331.57 | 365.53 | Upgrade
|
| Accounts Payable | 3.59 | 6.58 | 3.24 | 3 | 3.19 | 1.61 | Upgrade
|
| Accrued Expenses | 5.8 | 7.44 | 9.94 | 7.31 | 8.63 | 4.8 | Upgrade
|
| Current Portion of Leases | 0.36 | 0.35 | 0.85 | 0.53 | 0.4 | - | Upgrade
|
| Total Current Liabilities | 9.76 | 14.37 | 14.03 | 10.83 | 12.22 | 6.41 | Upgrade
|
| Long-Term Leases | 0.74 | 0.84 | 12.43 | 13.45 | 10.79 | - | Upgrade
|
| Total Liabilities | 10.5 | 15.21 | 26.46 | 24.28 | 23.01 | 6.41 | Upgrade
|
| Additional Paid-In Capital | 546.17 | 544.65 | 535.47 | 487.52 | 476.36 | 469 | Upgrade
|
| Retained Earnings | -386.15 | -368.71 | -310 | -241.04 | -167.73 | -109.88 | Upgrade
|
| Comprehensive Income & Other | 0.08 | 0.14 | 0.22 | -0.45 | -0.08 | - | Upgrade
|
| Total Common Equity | 160.11 | 176.08 | 225.69 | 246.03 | 308.56 | 359.12 | Upgrade
|
| Shareholders' Equity | 160.11 | 176.08 | 225.69 | 246.03 | 308.56 | 359.12 | Upgrade
|
| Total Liabilities & Equity | 170.61 | 191.29 | 252.15 | 270.31 | 331.57 | 365.53 | Upgrade
|
| Total Debt | 1.11 | 1.19 | 13.29 | 13.98 | 11.19 | - | Upgrade
|
| Net Cash (Debt) | 164.72 | 182.11 | 215.28 | 229.57 | 302.88 | 361.42 | Upgrade
|
| Net Cash Growth | -17.66% | -15.41% | -6.23% | -24.20% | -16.20% | 256.13% | Upgrade
|
| Net Cash Per Share | 3.19 | 3.53 | 4.48 | 5.04 | 6.71 | 25.16 | Upgrade
|
| Filing Date Shares Outstanding | 51.95 | 51.93 | 51.44 | 45.77 | 45.45 | 44.78 | Upgrade
|
| Total Common Shares Outstanding | 51.95 | 51.94 | 51.45 | 45.77 | 45.43 | 44.78 | Upgrade
|
| Working Capital | 153.74 | 161.29 | 193.38 | 236.17 | 289.07 | 358.35 | Upgrade
|
| Book Value Per Share | 3.08 | 3.39 | 4.39 | 5.38 | 6.79 | 8.02 | Upgrade
|
| Tangible Book Value | 160.11 | 176.08 | 225.69 | 246.03 | 308.56 | 359.12 | Upgrade
|
| Tangible Book Value Per Share | 3.08 | 3.39 | 4.39 | 5.38 | 6.79 | 8.02 | Upgrade
|
| Machinery | - | 1.82 | 3.17 | 2.53 | 2.28 | 2.01 | Upgrade
|
| Leasehold Improvements | - | 0.05 | 10.77 | 0.41 | 0.16 | 0.07 | Upgrade
|
Updated May 9, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.